Well okay I admit the title may sound exag
The FDA's Pharmacy Compounding Advisory Committee just voted YES on all four peptides reviewed today: BPC-157, KPV, TB-500, and WOW
Mild hyperhomocysteinemia was not associated with higher rates of stroke
Save up to 90% on Synjardy XR with Coupons, Discount Cards & Patient Assistance Programs Start Saving Today
Although the genetic effect sizes we detected are modest, it is likely that additional data will reveal further associations and increase the predictive utility of genetics in this context
Fig.3 Proportion of patients achieving MASH resolution without worsening of fibrosis with tirzepatide [6] While GLP-1 RAs are proving effective in treating MASH, their lack of direct action on liver tissue could limit their effectiveness in patients with advanced liver fibrosis or cirrhosis